MedPath

ltrasound evaluation of parasternal intercostal muscle and diaphragm in patients with stable chronic obstructive pulmonary disease

Completed
Conditions
stable chronic obstructive pulmonary disease
chronic obstructive pulmonary disease
diaphragm
parasternal muscle
ultrasound
Registration Number
TCTR20210402001
Lead Sponsor
Faculty of Medicine Siriraj Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
45
Inclusion Criteria

COPD group
1. Age >/= 40 years
2. Diagnosed COPD according to GOLD criteria (post-bronchodilator FEV1/FVC < 0.70)
3. Post-bronchodilator FEV1 35-79 %predicted within the past 6 months
Control group
1. Age >/= 40 years
2. Normal spirometry (FEV1/FVC >/= 0.70 and FVC >/= 80 %predicted)

Exclusion Criteria

COPD group
1. History of acute exacerbation of COPD within the past 3 months
2. History of thoracic surgery
3. Diagnosed diaphragm paralysis or chronic neuromuscular disease
4. Pregnant woman
5. Refuse to participate
Control group
1. History of thoracic surgery
2. Other respiratory diseases such as pneumothorax, pleural effusion, or pulmonary fibrosis
3. Pregnant woman
4. Refuse to participate

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Thickness of parasternal muscle 5 minutes Ultrasound
Secondary Outcome Measures
NameTimeMethod
Thickening fraction of parasternal muscle 5 mntues Ultrasound,Thickening fraction of diaphragm 5 minutes Ultrasound,Correlation between thickening fraction of parasternal muscle and diaphragm with severity of COPD 5 minutes Ultrasound
© Copyright 2025. All Rights Reserved by MedPath